tirzepatide surmount-1 nejm 2022 weight loss percent Tirzepatide: In the trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 Tirzepatide for Obesity: Highlights from
Description
Rated 5 out of 5 Amanda (verified owner) Very satisfied, Im getting closer to my goal weight and feeling more confident

These numbers are meaningfully higher than tirzepatide discontinuation rates and represent an important consideration for researchers planning long-term protocols

The first thing Colleen noticed was that her joint pain and inflammation improved right away

[9] [10] The peptide's mechanism involves binding to specific GHRH receptors on somatotroph cells, triggering a cascade that results in pulsatile growth hormone secretion that aims to support the body's natural GH release pattern
